Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,249

Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

for

Solid Tumors Harboring MET Amplification

Location: Nashville TN, Chicago IL, Durham NC, Grand Rapids MI,

Sponsor: AbbVie

Sex: All

Age: 12+

Code: NCT07196644

Phase2, Recruiting

Featured

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for

Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,

Location: Nashville TN, Cincinnati OH, Fairfax VA,

Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase2, Recruiting

Featured

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for

Non-Small Cell Lung Cancer

Location: Nashville TN, Knoxville TN, Fort Wayne IN,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07155187

Phase2, Phase3, Recruiting

Featured

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

for

Multiple Myeloma

Location: Nashville TN, Atlanta GA, Fort Wayne IN, Roanoke VA,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07095452

Phase2, Phase3, Recruiting

Featured

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for

Alopecia Areata

Location: Murfreesboro TN, Spartanburg SC, Mason OH,

Sponsor: AbbVie

Sex: All

Age: 12 - 63

Code: NCT06012240

Phase3, Recruiting

FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for

Hypothyroidism

Location: Nashville TN, Chattanooga TN, Knoxville TN, Canton GA,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting

FeaturedActive & Responsive

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for

Generalized Anxiety Disorder (GAD)

Location: Franklin TN, Huntsville AL, Marietta GA, Cincinnati OH,

Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT06846320

Phase2, Recruiting

Embo Registry; National Registry for Artery Embolization

for

Chronic Pain, Osteoarthritis, Knee, Osteoarthritis Thumb,

Location: Winchester TN, Cary NC

Sponsor: Vascular Solutions of North Carolina

Sex: All

Age: 18+

Code: NCT06477965

Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: Tullahoma TN, Bowling Green KY, Athens AL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

for

Plaque Psoriasis

Location: Goodlettsville TN, Murray KY, Sandy Springs GA,

Sponsor: Bristol-Myers Squibb

Sex: All

Age: 12 - 17

Code: NCT06979453

Phase3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for

Peripheral Artery Disease (PAD)

Location: Tullahoma TN, Knoxville TN, Jackson TN,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase3, Recruiting

The OBSERVE Protocol

for

Major Depression Disorder

Location: Nashville TN, Atlanta GA, Bellaire TX, Milford CT,

Sponsor: Yale University

Sex: All

Age: 0+

Code: NCT06725277

Recruiting

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

for

Depression

Location: Nashville TN, Atlanta GA, Bellaire TX, Milford CT,

Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06713616

Phase3, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for

Solid Tumors

Location: Nashville TN, Springfield IL, Salem VA, Naperville IL,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase3, Recruiting

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

for

Pulmonary Hypertension Associated With HFpEF

Location: Nashville TN, Alexander City AL, Indianapolis IN,

Sponsor: Tenax Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07288398

Phase3, Recruiting

Team Lifestyle Immersion Hypertension Control Project

for

Hypertension

Location: Nashville TN

Sponsor: Meharry Medical College

Sex: All

Age: 30 - 70+

Code: NCT07201948

Recruiting

Investigations of Reproductive Cancers in Women

for

Uterine Cancer

Location: Nashville TN, Birmingham AL, Memphis TN,

Sponsor: PinkDx, Inc.

Sex: Female

Age: 45 - 70+

Code: NCT06527157

Recruiting

A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families

for

Human Papilloma Virus, HPV-Related Carcinoma, Vaccine Refusal,

Location: Nashville TN

Sponsor: Meharry Medical College

Sex: All

Age: 18+

Code: NCT04380623

Recruiting

A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

for

Liver Cirrhosis

Location: Nashville TN, Columbus GA, Charleston SC,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT07325526

Phase2, Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for

Breast Cancer, TNBC - Triple-Negative Breast Cancer,

Location: Nashville TN, Birmingham AL, Carbondale IL,

Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

Paid Clinical Trials Murfreesboro

Filter results

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Interested in new trials?

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Embo Registry; National Registry for Artery Embolization

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

The OBSERVE Protocol

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Team Lifestyle Immersion Hypertension Control Project

Investigations of Reproductive Cancers in Women

A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families

A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies